Tecan Group AG (0QLN.L)

CHF 205.8

(-0.68%)

Operating Income Summary of Tecan Group AG

  • Tecan Group AG's latest annual operating income in 2023 was 135.96 Million CHF , down -6.84% from previous year.
  • Tecan Group AG's latest quarterly operating income in 2024 Q2 was 25.97 Million CHF , down 0.0% from previous quarter.
  • Tecan Group AG reported an annual operating income of 145.95 Million CHF in 2022, up 3.42% from previous year.
  • Tecan Group AG reported an annual operating income of 141.12 Million CHF in 2021, up 14.74% from previous year.
  • Tecan Group AG reported a quarterly operating income of 61.5 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Tecan Group AG reported a quarterly operating income of 135.96 Million CHF for 2023 FY, down -6.84% from previous quarter.

Annual Operating Income Chart of Tecan Group AG (2023 - 2002)

Historical Annual Operating Income of Tecan Group AG (2023 - 2002)

Year Operating Income Operating Income Growth
2023 135.96 Million CHF -6.84%
2022 145.95 Million CHF 3.42%
2021 141.12 Million CHF 14.74%
2020 122.99 Million CHF 38.33%
2019 88.91 Million CHF 1.73%
2018 87.4 Million CHF 6.91%
2017 81.76 Million CHF 19.09%
2016 68.65 Million CHF 2.58%
2015 66.92 Million CHF 16.11%
2014 57.64 Million CHF 5.84%
2013 54.46 Million CHF 4.12%
2012 52.3 Million CHF 2.02%
2011 51.27 Million CHF -8.4%
2010 55.97 Million CHF -6.07%
2009 59.58 Million CHF 91.04%
2008 31.19 Million CHF -48.27%
2007 60.29 Million CHF 18.57%
2006 50.85 Million CHF 104.84%
2005 24.82 Million CHF 48.22%
2004 16.74 Million CHF -24.46%
2003 22.17 Million CHF -50.4%
2002 44.7 Million CHF 0.0%

Peer Operating Income Comparison of Tecan Group AG

Name Operating Income Operating Income Difference
Relief Therapeutics Holding AG -110.82 Million CHF 222.683%
Santhera Pharmaceuticals Holding AG 68.84 Million CHF -97.5%
Basilea Pharmaceutica AG 19.2 Million CHF -607.977%
Bachem Holding AG 129.38 Million CHF -5.091%
Siegfried Holding AG 172.06 Million CHF 20.981%
Molecular Partners AG -61.1 Million CHF 322.503%